StonvexLoading…
StonvexStonvexStonvexCore line items from JBHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.00B | $12.09B | $12.83B | $14.81B |
Operating Income | $865.07M | $831.23M | $993.20M | $1.33B |
Net Income | $598.28M | $570.89M | $728.29M | $969.35M |
EPS (Diluted) | $6.12 | $5.56 | $6.97 | $9.21 |
Total Assets | $7.93B | $8.31B | $8.59B | $7.79B |
Total Liabilities | $4.36B | $4.30B | $4.48B | $4.12B |
Cash & Equivalents | $17.28M | $46.98M | $53.34M | $51.93M |
Free Cash Flow OCF − CapEx | $947.59M | $617.78M | $-117.81M | $236.09M |
Shares Outstanding | 94.59M | 100.56M | 103.22M | 103.74M |